Consequently, it is likely that OPG plays an anti-calcifying role that is consistent with increased levels of OPG during certain stages of the coronary heart disease, where OPG may be over-expressed to compensate for the deposition of calcium in the subendothelial space [14,37]. This evidence concerns the gene TNFRSF11B and coronary artery disorder.